Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guofeng Cheng

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
The Journal of General Virology|December 21, 2019
Establishment of infectious genotype 4 cell culture-derived hepatitis C virusNoriyuki Watanabe, Takaya Suzuki, Tomoko Date, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Plos One|July 1, 2015
The Differential Expression of Immune Genes between Water Buffalo and Yellow Cattle Determines Species-Specific Susceptibility to Schistosoma japonicum InfectionJianmei Yang, Zhiqiang Fu, Yang Hong, et al.
Fundamental Research|June 11, 2026
Endogenous iron biomineralization in the mouse spleen of metabolic diseasesRuowen Guo, Lei Zhang, Dongsheng Song, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 20, 2024
Effects of 1.5-9.4 T High Static Magnetic Fields on Alcoholic Liver Disease in MiceXinyu Wang, Chao Song, Chuanlin Feng, et al.
Antiviral Therapy|January 21, 2017
Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256Huiling Yang, Chris Yang, Yujin Wang, et al.
Journal of Virology|February 4, 2011
Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kineticsMaria V Pokrovskii, Caroline O Bush, Rudolf K F Beran, et al.
Journal of Hepatology|February 9, 2012
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis CEric J Lawitz, Daniel Gruener, John M Hill, et al.
Research (Washington, D.C.)|October 14, 2024
Erratum to "Enhanced Effects of Intermittent Fasting by Magnetic Fields in Severe Diabetes"Ying Wang, Chuanlin Feng, Biao Yu, et al.
Nature Materials|March 18, 2025
Atomic-scale interface strengthening unlocks efficient and durable Mg-based thermoelectric devicesWusheng Zuo, Hongyi Chen, Ziyi Yu, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
The Journal of General Virology|December 21, 2019
Establishment of infectious genotype 4 cell culture-derived hepatitis C virusNoriyuki Watanabe, Takaya Suzuki, Tomoko Date, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Plos One|July 1, 2015
The Differential Expression of Immune Genes between Water Buffalo and Yellow Cattle Determines Species-Specific Susceptibility to Schistosoma japonicum InfectionJianmei Yang, Zhiqiang Fu, Yang Hong, et al.
Fundamental Research|June 11, 2026
Endogenous iron biomineralization in the mouse spleen of metabolic diseasesRuowen Guo, Lei Zhang, Dongsheng Song, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 20, 2024
Effects of 1.5-9.4 T High Static Magnetic Fields on Alcoholic Liver Disease in MiceXinyu Wang, Chao Song, Chuanlin Feng, et al.
Antiviral Therapy|January 21, 2017
Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256Huiling Yang, Chris Yang, Yujin Wang, et al.
Journal of Virology|February 4, 2011
Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kineticsMaria V Pokrovskii, Caroline O Bush, Rudolf K F Beran, et al.
Journal of Hepatology|February 9, 2012
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis CEric J Lawitz, Daniel Gruener, John M Hill, et al.
Research (Washington, D.C.)|October 14, 2024
Erratum to "Enhanced Effects of Intermittent Fasting by Magnetic Fields in Severe Diabetes"Ying Wang, Chuanlin Feng, Biao Yu, et al.
Nature Materials|March 18, 2025
Atomic-scale interface strengthening unlocks efficient and durable Mg-based thermoelectric devicesWusheng Zuo, Hongyi Chen, Ziyi Yu, et al.
Pageof 14